Lemaitre Vascular LMAT
NASDAQ LMAT
$82.40 +0.08 (+0.10%)
As of: Aug 21, 2026 · 11:53 AM EDT

Lemaitre Vascular (LMAT) Short term Debt (2020 - 2021)

Lemaitre Vascular (LMAT) posted quarterly Short term Debt of $3.0 million for Q2 2021, up 50.0% year-over-year from $2.0 million in Q2 2020, and up 20.0% quarter-over-quarter from $2.5 million in Q4 2020.

Lemaitre Vascular (LMAT) Short term Debt (2020 - 2021) Analysis & Trends

Lemaitre Vascular (LMAT) has reported Short term Debt for 2 consecutive years, with $3.0 million the latest figure, recorded in Q2 2021.

  • In Q2 2021, Short term Debt rose 50.0% year-over-year to $3.0 million; the TTM figure through Jun 2021 stood at $3.0 million (up 50.0% YoY), while the FY2020 annual figure was $2.5 million, changed N/A from the prior year.
  • Short term Debt advanced to $3.0 million in Q2 2021 per LMAT's latest filing, from $2.5 million in the prior quarter.
  • Across five years, Short term Debt topped out at $3.0 million in Q2 2021 and bottomed at $2.0 million in Q2 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Intuitive Surgical 135.11 Bn 129.89 Bn 1.96 Bn
2 Becton Dickinson 52.51 Bn 51.65 Bn 2.32 Bn
3 Alcon 35.73 Bn 34.38 Bn 1.68 Bn
4 Resmed 33.94 Bn 32.47 Bn 861.22 Mn
5 Medline 29.02 Bn 26.34 Bn 2.22 Bn
6 West Pharmaceutical Services 24.95 Bn 24.51 Bn 329.20 Mn
7 Solventum 15.28 Bn 14.87 Bn 1.29 Bn
8 Cooper Companies 14.83 Bn 14.69 Bn 735.40 Mn
9 Baxter International 13.65 Bn 11.50 Bn 1.03 Bn
10 Lemaitre Vascular 1.88 Bn 1.51 Bn 50.76 Mn

Historic Data

Download Data
DateValue
Jun 30, 2021 3.00 Mn
Dec 31, 2020 2.50 Mn
Sep 30, 2020 2.25 Mn
Jun 30, 2020 2.00 Mn